1. Home
  2. PUK vs ONC Comparison

PUK vs ONC Comparison

Compare PUK & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prudential Public Limited Company

PUK

Prudential Public Limited Company

HOLD

Current Price

$31.19

Market Cap

38.7B

Sector

Finance

ML Signal

HOLD

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$308.54

Market Cap

31.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PUK
ONC
Founded
1848
2010
Country
Hong Kong
Switzerland
Employees
15338
12000
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.7B
31.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PUK
ONC
Price
$31.19
$308.54
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$385.10
AVG Volume (30 Days)
645.6K
201.9K
Earning Date
03-26-2026
05-06-2026
Dividend Yield
1.68%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$723.76
Revenue Next Year
$8.92
$15.04
P/E Ratio
$23.76
$614.06
Revenue Growth
N/A
N/A
52 Week Low
$22.14
$235.35
52 Week High
$34.03
$385.22

Technical Indicators

Market Signals
Indicator
PUK
ONC
Relative Strength Index (RSI) 53.74 52.82
Support Level $31.15 $302.26
Resistance Level $31.38 $316.25
Average True Range (ATR) 0.53 8.47
MACD -0.05 -0.61
Stochastic Oscillator 60.24 57.66

Price Performance

Historical Comparison
PUK
ONC

About PUK Prudential Public Limited Company

Originally established in 1848 as the Prudential Mutual Assurance, Investment, and Loan Association, Prudential has changed a lot since. Set up to sell life insurance and loans to the middle class, the company subsequently diversified into Europe and then North America with the purchase of Jackson National Life around 1985. During its time as owner of Jackson, Prudential focused on building a simple chassis-style product portfolio that allowed customers to choose from a variety of add-ons. The company also became renowned for its focus on building the internal capabilities required to support its strong product offerings, including compelling technology and a large well-trained wholesale salesforce.

About ONC BeiGene Ltd. American Depositary Shares

BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.

Share on Social Networks: